Several recent studies have focused attention on neuroendocrine differentiation (NED) in prostatic carcinoma (PC). Clinical studies have shown PC with NED to behave aggressively and to be associated with poor prognosis. To evaluate NED as an independent prognostic factor, we conducted a retrospectiv
Clinically localized prostatic carcinoma
โ Scribed by David F. Paulson
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 120 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostate brachytherapy is an effective treatment option for clinically organ-confined prostate carcinoma. Observed 5-and 10-year follow-up have documented prostate-specific antigen (PSA) levels that were comparable to published radical prostatectomy series and were better than several published exte
## Background: This investigation was conducted to develop an enhanced prognostic system based on readily available and independently predictive tumor-related factors for patients with clinically localized prostate carcinoma. ## Methods: The outcome of 500 patients treated solely with irradiation
## Background: Increasingly, prostate carcinoma is diagnosed through screening. however, little is known regarding factors that influence a patient's decision concerning the treatment choices presented to him. ## Methods: Subjects were prostate carcinoma patients detected through the washington u
Others are larger or of higher grade or more extensive. These ''clini-Medicine, 6560 Fannin, Suite 2100, Houston, cally important'' carcinomas are much more likely to invade and TX 77030. metastasize within years, leading to the eventual death of the patient. The risk to life and health posed by e